Gainers Jaguar Health (NASDAQ:JAGX) stock moved upwards by 34.0% to $6.34 during Tuesday's pre-

Medical technology provider HeartBeam, Inc. (NASDAQ:BEAT) received Breakthrough Device Designation f

HeartBeam secures an expedited FDA designation for its 3D ECG at-home heart attack assessment tool,

Gainers HeartBeam (NASDAQ:BEAT) stock moved upwards by 70.5% to $0.74 during Monday's regular s

U.S. stocks rose Monday: Dow +0.2%, S&P 500 +0.62%, Nasdaq +0.84%. Materials led; ISM services P

U.S. stocks mixed: Nasdaq and S&P 500 rose while Dow dipped. Weak jobs data pressured outlook; o

The designation recognizes the potential of HeartBeam’s 3D ECG technology, which captures the heart’

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Receives FDA Breakthrough Device Designation for Hea

HeartBeam, Inc. (NASDAQ: BEAT - Get Free Report) has been given an average rating of "Moderate Buy"

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. Letter to Shareholders.

On August 14, 2026, HeartBeam, Inc. (the "Company"), entered into an At-The-Market Equity Of

Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular

HeartBeam, Inc. (BEAT) Q2 2026 Earnings Call Transcript

HeartBeam (NASDAQ:BEAT) held its second-quarter earnings conference call on Thursday. Below is the c

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2026 Results.

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2026 Results Conference Call

Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve car

Maxim Group analyst Anthony Vendetti initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy rat

[url="]HeartBeam, Inc.[/url] (NASDAQ: BEAT), a medical technology company focused on transforming ca

Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilitiesAcoustic s

Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-b

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Completes Enrollment in Heart Attack Detection Pilot

Company will license its 3D ECG signal technology to established partners, moving beyond direct medi

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Strategic Shift to Accelerate Global Adopt

[url="]HeartBeam, Inc.[/url] (NASDAQ: BEAT), a medical technology company focused on transforming ca

Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces New Peer-Reviewed Article Demonstrating Po

HeartBeam (BEAT) might move higher on growing optimism about its earnings prospects, which is reflec

HC Wainwright & Co. analyst Yi Chen maintains HeartBeam (NASDAQ:BEAT) with a Buy and lowers t

Benchmark analyst Bill Sutherland maintains HeartBeam (NASDAQ:BEAT) with a Speculative Buy and lo

HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.12) per share which beat the analyst consen

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2026 Results.

The study is being conducted at two leading hospitals in Belgrade, Serbia. The initiation of the pil

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG

Leading concierge practice Atelier Health, led by physicians affiliated with Cedars-Sinai, will now

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Expands Commercial Presence Across Four Key U.S. Mar

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2026 Results Conference Call o

HeartBeam, Inc. (NASDAQ: BEAT - Get Free Report) Director Mark Strome acquired 750,000 shares of the

NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-ye

B. Riley Securities analyst Anderson Schock initiates coverage on HeartBeam (NASDAQ:BEAT) with a

Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrade

D. Boral Capital analyst Jason Kolbert initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy r

HC Wainwright & Co. analyst Yi Chen reiterates HeartBeam (NASDAQ:BEAT) with a Buy and maintai

HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.14) per share which missed the analyst cons